[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more Integrated or stand alone Drug Discovery services (from hit findings to IND), to discover & evaluate the therapies of tomorrow together.
Value creation through innovative technologies & R&D partnerships
For Oncodesign, artificial intelligence (AI) is a powerful tool for accelerating and making drug development more reliable.
For more than 25 years, Oncodesign has been investing in precision medicine innovation technologies, which are essential from the very first stages of the Drug Discovery process.
Oncodesign’s mission is to discover new innovative therapies that are effective against cancers and serious diseases with no known treatments.
Here is our April 2020 issue which details the new organization of the Group into 3 Business Units. Interviews and articles on the menu.
Anatomy of the new face of Oncodesign: BU Service, BU Biotech & BU Artificial Intelligence.
Without forgetting the editorial by Ph. Genne entitled “how much is a human life worth”.
“Behind any disaster, there is the promise of reconstruction and it is in this direction that we must look …”.
18 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260
Receive our general letter or our financial news!